Page 167 - Small Animal Internal Medicine, 6th Edition

CHAPTER 6 Acquired Valvular and Endocardial Disease 139

Dillon AR, et al. Left ventricular remodeling in preclinical experi- Moesgaard SG, et al. Flow-mediated vasodilation measurements in
mental mitral regurgitation of dogs. J Vet Cardiol. 2012;14:73–92. Cavalier King Charles Spaniels with increasing severity of myxo-
VetBooks.ir tive heart failure in Cavalier King Charles Spaniels with mitral Moonarmart W, et al. N-terminal pro B-type natriuretic peptide
matous mitral valve disease. J Vet Intern Med. 2012;26:61–68.
Eriksson AS, et al. Increased NT-proANP predicts risk of conges-
and left ventricular diameter independently predict mortality in
regurgitation caused by myxomatous valve disease. J Vet Cardiol.
2014;16:141–154. dogs with mitral valve disease. J Small Anim Pract. 2010;51:84–96.
Falk T, et al. Cardiac troponin-I concentration, myocardial arterio- Muzzi RA, et al. Regurgitant jet area by Doppler color flow mapping:
sclerosis, and fibrosis in dogs with congestive heart failure quantitative assessment of mitral regurgitation severity in dogs.
because of myxomatous mitral valve disease. J Vet Intern Med. J Vet Cardiol. 2003;5:33–38.
2013;27:500–506. Ohad DG, et al. Sleeping and resting respiratory rates in dogs with
Ferasin L, et al. Risk factors for coughing in dogs with naturally subclinical heart disease. J Am Vet Med Assoc. 2013;243:839–843.
acquired myxomatous mitral valve disease. J Vet Intern Med. Oui H, et al. Measurements of the pulmonary vasculature on tho-
2013;27:286–292. racic radiographs in healthy dogs compared to dogs with mitral
Fox PR. Pathology of myxomatous mitral valve disease in the dog. regurgitation. Vet Radiol Ultrasound. 2015;56:251–256.
J Vet Cardiol. 2012;14:103–126. Oyama MA. Neurohormonal activation in canine degenerative
Gordon SG, et al. Retrospective review of carvedilol administration mitral valve disease: implications on pathophysiology and treat-
in 38 dogs with preclinical chronic valvular heart disease. J Vet ment. J Small Anim Pract. 2009;50:3–11.
Cardiol. 2012;14:243–252. Polizopoulou ZS, et al. Serial analysis of serum cardiac troponin I
Gouni V, et al. Quantification of mitral valve regurgitation in dogs changes and correlation with clinical findings in 46 dogs with
with degenerative mitral valve disease by use of the proximal mitral valve disease. Vet Clin Pathol. 2014;43:218–225.
isovelocity surface area method. J Am Vet Med Assoc. 2007;231: Reineke EL, Burkett DE, Drobatz KJ. Left atrial rupture in dogs: 14
399–406. cases (1990-2005). J Vet Emerg Crit Care. 2008;18:158–164.
Guglielmini C, et al. Use of the vertebral heart score in coughing Reynolds CA, et al. Prediction of first onset of congestive heart
dogs with chronic degenerative mitral valve disease. J Vet Med failure in dogs with degenerative mitral valve disease: the
Sci. 2009;71:9–13. PREDICT cohort study. J Vet Cardiol. 2012;14:193–202.
Haggstrom J, et al. Effect of pimobendan or benazepril hydrochlo- Sargent J, et al. Echocardiographic predictors of survival in dogs
ride on survival times in dogs with congestive heart failure with myxomatous mitral valve disease. J Vet Cardiol. 2015;17:
caused by naturally occurring myxomatous mitral valve disease: 1–12.
the QUEST study. J Vet Intern Med. 2008;22:1124–1135. Schober KE, et al. Effects of treatment on respiratory rate, serum
Hezzell MJ, et al. The combined prognostic potential of serum natriuretic peptide concentration, and Doppler echocardio-
high-sensitivity cardiac troponin I and N-terminal pro-B-type graphic indices of left ventricular filling pressure in dogs with
natriuretic peptide concentrations in dogs with degenerative congestive heart failure secondary to degenerative mitral valve
mitral valve disease. J Vet Intern Med. 2012;26:302–311. disease and dilated cardiomyopathy. J Am Vet Med Assoc.
Hezzell MJ, et al. Selected echocardiographic variables change more 2011;239:468–479.
rapidly in dogs that die from myxomatous mitral valve disease. Schober KE, et al. Detection of congestive heart failure in dogs by
J Vet Cardiol. 2012;14:269–279. Doppler echocardiography. J Vet Intern Med. 2010;24:1358–1368.
Kellihan HB, Stepien RL. Pulmonary hypertension in canine degen- Serres F, et al. Chordae tendineae rupture in dogs with degenerative
erative mitral valve disease. J Vet Cardiol. 2012;14:149–164. mitral valve disease: prevalence, survival, and prognostic factors
Kim JH, Park HM. Usefulness of conventional and tissue Doppler (114 cases, 2001-2006). J Vet Intern Med. 2007;21:258–264.
echocardiography to predict congestive heart failure in dogs with Singh MK, et al. Bronchomalacia in dogs with myxomatous mitral
myxomatous mitral valve disease. J Vet Intern Med. 2015;29: valve degeneration. J Vet Intern Med. 2012;26:312–319.
132–140. Tarnow I, et al. Predictive value of natriuretic peptides in dogs with
Lake-Bakaar GA, et al. Effect of pimobendan on the incidence of mitral valve disease. Vet J. 2009;180:195–201.
arrhythmias in small breed dogs with myxomatous mitral valve Uechi M. Mitral valve repair in dogs. J Vet Cardiol. 2012;14:185–192.
degeneration. J Vet Cardiol. 2015;17:120–128.
Lefebvre HP, et al. Safety of spironolactone in dogs with chronic heart Infective Endocarditis
failure because of degenerative valvular disease: a population- Breitschwerdt EB. Bartonellosis of the cat and dog. Plumb’s Thera-
based, longitudinal study. J Vet Intern Med. 2013;27:1083–1091. peutics Brief. 2015;18–23.
Ljungvall I, et al. Cardiac troponin I is associated with severity of Breitschwerdt EB, et al. Bartonellosis: an emerging infectious
myxomatous mitral valve disease, age, and C-reactive protein in disease of zoonotic importance to animals and human beings. J
dogs. J Vet Intern Med. 2010;24:153–159. Vet Emerg Crit Care. 2010;20:8–30.
Lombard CW, Jons O, Bussadori CM. Clinical efficacy of pimo- Calvert CA, Thomason JD. Cardiovascular infections. In: Greene
bendan versus benazepril for the treatment of acquired atrio- CE, ed. Infectious diseases of the dog and cat. 4th ed. St Louis:
ventricular valvular disease in dogs. J Am Anim Hosp Assoc. Elsevier; 2012:912–936.
2006;42:249–261. Glickman LT, et al. Evaluation of the risk of endocarditis and other
López-Alvarez J, et al. Clinical severity score system in dogs with cardiovascular events on the basis of the severity of periodontal
degenerative mitral valve disease. J Vet Intern Med. 2015;29: disease in dogs. J Am Vet Med Assoc. 2009;234:486–494.
575–581. MacDonald K. Infective endocarditis in dogs: diagnosis and
Lord PF, et al. Radiographic heart size and its rate of increase as therapy. Vet Clin North Am Small Anim Pract. 2010;40:665–684.
tests for onset of congestive heart failure in Cavalier King Charles MacDonald KA. Infective endocarditis. In: Bonagura JD, Twedt
Spaniels with mitral valve regurgitation. J Vet Intern Med. DC, eds. Kirk’s current veterinary therapy XV. St Louis: Elsevier;
2011;25:1312–1319. 2014:e291–e299.